Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body
Open Access
- 1 September 2020
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 259 (2) , 515-526
Abstract
Purpose: The eye and its adnexal structures can give rise to first or consecutive primary malignancies or to encounter metastasis. Our aim was to define the characteristics of the second primary neoplasms affecting the eye and its adnexa and find the risk modifying factors for them after malignancies elsewhere in the body. Methods: We have queried the Surveillance, Epidemiology and End-Results “SEER”-9 program of the National Cancer Institute for the malignancies of the eye and its adnexa that occurred between 1973 and 2015. The malignancies were ordered chronologically according to their incidence: first or second primary malignancies. The tumors were classified according to ICD-O-3 classification. Standardized incidence ratios (SIR) and survival probabilities were calculated for subgroups. Results: Among 3,578,950 cancer patients, 1203 experienced a second malignancies of the eye and its adnexa. The first malignancy was diagnosed between 50 and 69 years of age in 58.94% of them. The eyelid showed 280 events, while 50 in lacrimal gland, 181 in the orbit, 21 in the overlapping lesions, 15 in optic nerve, 148 in the conjunctiva, 9 in the cornea, 6 in the Retina, 379 in the choroid, and 93 in the ciliary body. The SIR of a second malignancy after a prior non-Hodgkin lymphoma was 2.42, and in case of previous skin carcinomas it was 3.02, melanoma of skin, and 2.13 and 1.58 in oral cavity/pharynx malignancies. The second ocular and adnexal neoplasms increased steadily over the 5-year periods on contrary to first primary neoplasms. The survival of patients affected with first ocular and adnexal neoplasms was significantly higher than those with second ocular and adnexal neoplasms. On the other side, second primary ocular and adnexal tumors showed a better survival than second primary malignancies elsewhere. Conclusions: The epidemiological differences between first and second ocular and adnexal primaries suggest different underlying mechanisms. Careful ocular examination should be integrated in the long-term follow-up plan of cancer patients. Special attention should be given to patients with non-Hodgkin’s lymphoma and melanoma as first primary.Keywords
Funding Information
- Deutscher Akademischer Austauschdienst (57147166)
This publication has 30 references indexed in Scilit:
- Orbital metastases in Italy2015
- Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control StudyJournal of Breast Cancer, 2015
- Orbital tumors in USA: Difference in survival patternsCancer Epidemiology, 2014
- Risk for second malignancies in non-Hodgkin’s lymphoma survivors: a meta-analysisAnnals of Oncology, 2011
- Second Primary Cancer After Radiotherapy for Prostate Cancer—A SEER Analysis of Brachytherapy Versus External Beam RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelidInternational Journal of Dermatology, 2008
- Second primary cancers among 109 000 cases of non-Hodgkin's lymphomaBritish Journal of Cancer, 2005
- Metastases in the ophthalmic region in Denmark 1969–98. A histopathological studyActa Ophthalmologica Scandinavica, 2003
- Ocular metastases from breast carcinoma: A multicentric retrospective study.Oncology Reports, 2000
- Orbital metastases: diagnosis and courseBritish Journal of Ophthalmology, 1997